Stockscreener 앱 받기
60.49
3.31%
1.94
시간 외 거래:
60.40
-0.09
-0.15%
전일 마감가:
$58.55
열려 있는:
$58.55
하루 거래량:
3.33M
Relative Volume:
2.99
시가총액:
$4.83B
수익:
$541.74M
순이익/손실:
$88.01M
주가수익비율:
55.69
EPS:
1.0862
순현금흐름:
$155.34M
1주 성능:
+12.79%
1개월 성능:
+36.82%
6개월 성능:
+42.36%
1년 성능:
+125.62%
1일 변동 폭
$58.06
$60.83
1주일 범위
$52.36
$60.83
52주 변동 폭
$22.61
$60.83
Veracyte Inc Stock (VCYT) Company Profile
명칭
Veracyte Inc
전화
(650) 243-6300
주소
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT vs TMO, DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
60.49 | 4.67B | 541.74M | 88.01M | 155.34M | 1.0862 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | Jefferies | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Underweight |
| 2025-10-20 | 개시 | Canaccord Genuity | Hold |
| 2025-03-20 | 개시 | Craig Hallum | Buy |
| 2024-12-05 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-10-16 | 개시 | UBS | Buy |
| 2024-10-10 | 개시 | Guggenheim | Buy |
| 2024-02-23 | 재확인 | Needham | Buy |
| 2023-01-18 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-11-18 | 재개 | Goldman | Buy |
| 2021-06-15 | 개시 | Raymond James | Outperform |
| 2021-02-18 | 재개 | Needham | Buy |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-09 | 개시 | Morgan Stanley | Underweight |
| 2019-07-31 | 개시 | Lake Street | Buy |
| 2019-07-02 | 개시 | Needham | Buy |
| 2018-11-29 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-10-31 | 업그레이드 | Janney | Neutral → Buy |
| 2017-11-07 | 다운그레이드 | Janney | Buy → Neutral |
| 2017-11-07 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-08-31 | 재개 | BTIG Research | Buy |
| 2016-11-14 | 재개 | Leerink Partners | Outperform |
| 2015-12-18 | 개시 | Cantor Fitzgerald | Buy |
| 2015-06-11 | 재확인 | Leerink Partners | Outperform |
| 2013-11-26 | 개시 | William Blair | Outperform |
모두보기
Veracyte Inc 주식(VCYT)의 최신 뉴스
Price to book forward of Veracyte, Inc. – FWB:12V - TradingView
Enterprise value to EBITDA forward of Veracyte, Inc. – NASDAQ:VCYT - TradingView
What to Know About This $197,000 Veracyte Insider Sale After a 120% Stock Rally - Yahoo Finance
Veracyte, Inc. Actuals & Estimates (TRADEGATE:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (MUN:12V) - TradingView
Veracyte, Inc. Actuals & Estimates (DUS:12V) - TradingView
Q1 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q4 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q2 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Q3 2025 Veracyte Inc Earnings Call Transcript - GuruFocus
Veracyte, Inc. Actuals & Estimates (NASDAQ:VCYT) - TradingView
Veracyte Inc (VCYT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
VCYT Forecast — Price Target — Prediction for 2027 - TradingView
12V Forecast — Price Target — Prediction for 2027 - TradingView
Veracyte Inc (VCYT) Shares Surge 3.1% -- What GF Score of 75 Tel - GuruFocus
Veracyte Jumps 7.2% Amid Sector-Wide Rally - AlphaStreet
Veracyte stock hits 52-week high at 55.32 USD - Investing.com
Veracyte stock hits 52-week high at 55.32 USD By Investing.com - Investing.com Canada
Insider Sell Alert: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Form 4 Veracyte Inc For: 22 June By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock By Investing.com - Investing.com South Africa
Veracyte director Karin Eastham sells $197,234 in stock - Investing.com
Veracyte (VCYT) director logs 3,729-share Rule 10b5-1 stock sale - Stock Titan
VCYT News | VERACYTE INC (NASDAQ:VCYT) - ChartMill
[144] VERACYTE, INC. SEC Filing - Stock Titan
VCYT|Veracyte Inc|Price:53.630|Chg%:2.34 - TradingKey
Veracyte Inc (VCYT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Veracyte Inc (VCYT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Veracyte Inc (VCYT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Veracyte Inc (VCYT) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Veracyte Inc (VCYT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Veracyte Inc (VCYT) Institutional Confidence - TradingKey
Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Veracyte Inc (VCYT) Valuation: PE, PB & Fair Value Analysis - TradingKey
Veracyte stock hits 52-week high at 50.81 USD By Investing.com - Investing.com South Africa
Is Veracyte Inc (VCYT) Overvalued After 3.5% Rally? GF Value Say - GuruFocus
Veracyte stock hits 52-week high at 50.81 USD - Investing.com
High Growth Momentum Breakout Setup: Veracyte Inc (NASDAQ:VCYT) - ChartMill
Veracyte (VCYT) director Jens Holstein awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Eliav Barr receives 5,272 restricted stock units - Stock Titan
Director at Veracyte (VCYT) receives grant of 5,272 restricted stock units - Stock Titan
Evan Jones of Veracyte (NASDAQ: VCYT) receives 5,272 restricted stock units - Stock Titan
Director at VERACYTE, INC. (VCYT) awarded 5,272 restricted stock units - Stock Titan
Veracyte (VCYT) director Robert Epstein receives 5,272-share RSU grant - Stock Titan
[Form 4] VERACYTE, INC. Insider Trading Activity - Stock Titan
Veracyte (VCYT) director awarded 5,272 RSUs vesting over one year - Stock Titan
Veracyte, Inc. 2023 Equity Incentive Plan Amended – SEC 8-K Filing Details and Company Information - Minichart
Veracyte shareholders endorse board, pay and incentive plans - The Globe and Mail
FMR LLC's Strategic Acquisition of Veracyte Inc Shares - GuruFocus
Veracyte (VCYT) investors back 3.5M-share equity plan increase and elect full board - Stock Titan
Veracyte (NASDAQ:VCYT) Hits New 12-Month HighHere's Why - MarketBeat
Veracyte Inc (VCYT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
0.62%
자본화:
|
볼륨(24시간):